BioSpace News Archive

DICE Therapeutics, Inc. reported financial results and business highlights for the fourth quarter and full year ended December 31, 2021.

Venus Concept Inc., a global medical aesthetic technology leader, announced that management will present at the Maxim Virtual Growth Conference, which is being held virtually from March 28th-30th.

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, announced the appointment of Dr. Randall Kaye as Chief Medical Officer.

Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced the appointment of Ms. Ruth Alon to its Board of Directors, effective immediately.

Marpai, Inc. will host a conference call and webcast on Thursday, March 31 at 8:30 a.m. ET to answer questions about the Company’s operational and financial highlights for its fourth quarter.

Haemonetics Corporation (NYSE: HAE) today announced that James C. D’Arecca will join the Company as Executive Vice President, Chief Financial Officer, effective April 11, 2022.

Statera Biopharma, Inc., a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced it has commenced an underwritten public offering.

Akerna today reported its unaudited financial results for the quarter and year ended December 31, 2021.

Inari Medical, Inc. announced that it has completed the sale of an additional 300,000 shares of its common stock, pursuant to the exercise in full of the over-allotment option granted to the underwriters in connection with Inari’s recently completed underwritten public offering of 2,000,000 shares of common stock, at the public offering price of $81.00 per share, less underwriting discounts and commissions.

Orphazyme A/S, today initiated the delisting and filed a Form 25 with the Securities and Exchange Commission (“SEC”). The delisting is expected to become effective on March 31, 2022.